Log In
Print
BCIQ
Print
Print this Print this
 

Nexagon

  Manage Alerts
Collapse Summary General Information
Company CoDa Therapeutics Inc.
DescriptionAntisense oligonucleotide that targets gap junction protein alpha 1, 43kDa (GJA1; CX43; connexin-43)
Molecular Target Gap junction protein alpha 1, 43kDa (GJA1) (CX43) (connexin-43)
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA: Antisense

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today